AI assistant
Sending…
ABBOTT LABORATORIES — Remuneration Information 2014
Apr 14, 2014
29777_rns_2014-04-14_78ccc415-f207-421d-97ed-029e637812f4.zip
Remuneration Information
Open in viewerOpens in your device viewer
DEFA14A 1 a14-10520_1defa14a.htm DEFA14A
| UNITED STATES | ||
|---|---|---|
| SECURITIES AND EXCHANGE COMMISSION | ||
| Washington, D.C. 20549 | ||
| SCHEDULE 14A | ||
| Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) | ||
| Filed by the Registrant x | ||
| Filed by a Party other than the Registrant o | ||
| Check the appropriate box: | ||
| o | Preliminary Proxy Statement | |
| o | Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) | |
| o | Definitive Proxy Statement | |
| x | Definitive Additional Materials | |
| o | Soliciting Material under §240.14a-12 | |
| Abbott Laboratories | ||
| (Name of Registrant as Specified In Its Charter) | ||
| (Name of Person(s) Filing Proxy Statement, if other than the Registrant) | ||
| Payment of Filing Fee (Check the appropriate box): | ||
| x | No fee required. | |
| o | Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11. | |
| (1) | Title of each class of securities to which transaction applies: | |
| (2) | Aggregate number of securities to which transaction applies: | |
| (3) | Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined): | |
| (4) | Proposed maximum aggregate value of transaction: | |
| (5) | Total fee paid: | |
| o | Fee paid previously with preliminary materials. | |
| o | Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing. | |
| (1) | Amount Previously Paid: | |
| (2) | Form, Schedule or Registration Statement No.: | |
| (3) | Filing Party: | |
| (4) | Date Filed: |
SEQ.=1,FOLIO='',FILE='C:\JMS\107202\14-10520-1\task6698472\10520-1-ba.htm',USER='107202',CD='Apr 13 23:14 2014'
The shareholder proponents of the Incentive Compensation Compliance Costs shareholder proposal (Item 6 on Proxy Card) set forth in Abbotts Notice of Annual Meeting of Shareholders and Proxy Statement for the 2014 Annual Meeting of Shareholders to be held on Friday, April 25, 2014, have withdrawn the proposal. Shareholders will not be asked to vote on the proposal at the Annual Meeting.
SEQ.=1,FOLIO='',FILE='C:\JMS\108196\14-10520-1\task6699470\10520-1-bc.htm',USER='108196',CD='Apr 14 20:46 2014'
More from ABBOTT LABORATORIES
Regulatory Filings
2026
May 27
Major Shareholding Notification
2026
Apr 29
Interim / Quarterly Report
2026
Apr 29
Regulatory Filings
2026
Apr 27
Regulatory Filings
2026
Apr 24
Legal Proceedings Report
2026
Apr 17
Earnings Release
2026
Apr 16
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 25
Director's Dealing
2026
Mar 25